ELIZABETH CERCONE: Open Payments
NPI 1821335993 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 24 payments from 15 companies in 2025. Trend: 2023 $1,011 · 2024 $884 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $95 |
| Boston Scientific Corporation | 1 | $78 |
| Neurocrine BioSciences, Inc. | 1 | $67 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Astellas Pharma US Inc | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Amgen Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
Products named: WATCHMAN FLX, INGREZZA, Wegovy, NEXLETOL, Veozah, Ozempic, OTEZLA, REXULTI.
Industry payments across FL — which companies pay providers there.
